Lung cancer experts are calling for a fairer reimbursement process for anticancer drugs, criticizing the current system that requires patient petitions for insurance benefits. They highlight the ambiguity in reimbursement criteria and the need for transparent, science-based evaluations to ensure optimal treatment access. Concerns were raised about the disproportionate funding for oriental medicine compared to effective cancer treatments, urging a reevaluation of healthcare financing priorities.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.